Enact Inc. (ACT) Business Metric Overview - Stocknear

Enact Inc.

NASDAQ: ACT · Real-Time Price · USD
38.40
0.64 (1.69%)
At close: Sep 04, 2025, 3:59 PM
38.40
0.00%
After-hours: Sep 04, 2025, 04:37 PM EDT

Enact Revenue Breakdown

Period Ending Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Actavis Pharma Segment Revenue 24.9M 43.7M 9.7M
Actavis Pharma Segment Revenue Growth -43.02% +350.52% n/a
Actavis Specialty Brands Segment Revenue 16.1M 17.9M 14.5M
Actavis Specialty Brands Segment Revenue Growth -10.06% +23.45% n/a
Anda Distribution Segment Revenue 307.1M 275.8M 231M
Anda Distribution Segment Revenue Growth +11.35% +19.39% n/a

Revenue by Geography

Period Ending Dec 31, 2012
United States Revenue 4.72B
United States Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Selling, General, and Administrative Revenue n/a n/a n/a n/a 112.5M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling, General, and Administrative Revenue Growth n/a n/a n/a -100.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a